Laura L. Kummer
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Heterogeneous Activated B Cell Compartments Arising Early and Transiently After SARS-CoV-2 Vaccination.
Journal: European journal of immunology
Published: July 04, 2025
Combining Activation-Induced Markers With PD-L1 Selectively Enhances Detection of Antigen-Specific T Cells in Virus-Infected Individuals.
Journal: Journal of immunology research
Published: June 20, 2025
SARS-CoV-2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults.
Journal: European journal of immunology
Published: March 11, 2025
Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy.
Journal: The Journal of dermatology
Published: October 24, 2024
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy.
Journal: The Journal of allergy and clinical immunology
Published: December 23, 2023
Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseases.
Journal: European journal of neurology
Published: December 20, 2023
Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection.
Journal: Frontiers in immunology
Published: October 13, 2023
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: July 14, 2023
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
Journal: BMC infectious diseases
Published: November 15, 2022
Last Updated: 09/26/2026